News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Paolo Tarantino: Pleased to Welcome Prof. Al-Shamsi to Dana-Farber Cancer Institute
Paolo Tarantino/LinkedIn
May 30, 2025, 18:31

Paolo Tarantino: Pleased to Welcome Prof. Al-Shamsi to Dana-Farber Cancer Institute

Paolo Tarantino, Research Fellow at Dana-Farber Cancer Institute, shared a post on LinkedIn:

“Huge pleasure to welcome Prof. Al-Shamsi to Dana-Farber Cancer Institute this morning for terrific discussions on the rapidly evolving treatment landscape in breast oncology.”

More posts featuring Paolo Tarantino.

cancer Dana-Farber Cancer Institute Humaid Al-Shamsi OncoDaily Oncology Paolo Tarantino
Special Coverage
Blog
Jul 2, 2025, 20:46
New EU-funded Project PredictAYA - European Cancer Organisation
Blog
Jul 2, 2025, 20:37
Jame Abraham: Thank you Mariam AlHilli for Hosting the Father of Targeted Therapy in Breast Cancer
Blog
Jul 2, 2025, 20:25
Wafik El-Deiry: Honored to Meet Christopher Macchio
Insight
Jul 2, 2025, 20:16
Supriya Peshin on Rare Metastatic Pathways of Renal Cell Carcinoma
Blog
Jul 2, 2025, 17:48
Riya Patel: First Day as GI Medical Oncologist at the Zuckerberg Cancer Center
Blog
Jul 2, 2025, 17:38
Sergio Cifuentes: Important Information for Colleagues from LATAM Interested in GI Oncology
Blog
Jul 2, 2025, 17:27
Sarah Sammons: Dana-Farber’s Breast Oncology Center and Dr. Waks Debates Standard of Care in Stage II/III Her2+ Breast Cancer
Blog
Jul 2, 2025, 17:12
Benjamin Schrank: I’ve Joined MD Anderson Cancer Center as an Assistant Professor and Physician-Scientist in Radiation Oncology
Blog
Jul 2, 2025, 16:59
Salvador Jaime-Casas: The promise and pitfalls of predictive biomarkers in mUC
Blog
Jul 2, 2025, 16:42
Katsuaki Maehara: TTF-1 is a New Marker to Identify Patients Best Suited for Lung Cancer KRAS Inhibitors 
Insight
Jul 2, 2025, 16:16
Paolo Tarantino: Randomized phase 2 trial of neoadjuvant ARX788 + Pyrotinib vs TCHP for HER2+ BC
Blog
Jul 2, 2025, 16:01
Naveen Pemmaraju: A Very Happy July 1 to All Starting Their Medical Journey